UltraCare Liaison Kanagawa, Shizuoka
Share
Job Location:
Monthly Salary:
Posted on:
Yesterday
Vacancies:
1 Vacancy
Job Summary
Position Summary:
ultrafocused Work together to fearlessly uncover new possibilities
Ultragenyx Japanでは希少疾患領域で革新的な治療選択肢を届けるため担当テリトリーで主体的にビジネスを推進できる営業UltraCareLiaisonMR職を募集しています
ムコ多糖症VII型MPS VII家族性高コレステロール血症ホモ接合体HoFHそして2026年上市予定の調査脂肪酸代謝異常症LCFAOD治療薬の情報提供を担い患者さんフォーカスの環境で成果を生み出すことが求められます
変革を牽引できるビジネス感覚と高いコミュニケーション力を持ち新規拡大市場で実績を築いてきた方に最適なポジションです
希少疾患領域に貢献したい情熱を持つ方にとって非常にユニークで稀少なキャリア機会です
Work Model:
Field: Officially documented as working as a member of the Ultragenyx field team generally interacting with third parties on behalf of Ultragenyx.
Responsibilities:
- 担当テリトリーにおけるMPS VIIHoFHLC-FAOD治療薬のテリトリープランを策定実行し売上目標を達成する
- テリトリービジネスオーナーとしてインパクト分析テリトリー分析を行い診断医療従事者教育治療アクセス向上を最適化する
- テリトリーおよびアカウントプランを通じてPatient Identificationと市場開発を推進し販売機会を継続的に評価しながらビジネスを維持成長させる
- 社内外の多様なステークホルダーと効果的な関係を構築しコミュニケーションスタイルを柔軟に調整しつつ合意形成と意思決定をリードする
- Ultragenyxの方針SOPコンプライアンスに基づきKey Opinion Leaderや医療従事者とのエンゲージメントを推進する
- 重要アカウントに対して適切効率的なカバレッジを実現するため日次週次で出張計画およびコールプランを立案実行する
- PMS市販後調査を適切かつ迅速に収集し関連部門と連携して正確な情報提供報告を行う
- スタートアップ環境の一員として社内プロセスや業務ルールの構築に貢献し定量定性の両面で担当エリアを超えた全国レベルのインパクトを示す
Requirements:
- 学士号以上を有しサイエンスヘルスケア関連領域で10年以上のビジネス経験うち8年以上はヘルスケアまたはバイオテック業界希少疾患や家族性高コレステロール血症HoFH代謝異常症領域の経験があれば尚良い
- 事業戦略の立案力洞察力を持ち主体的に周囲をリードできること
- メディカルクリニカルオペレーションPatient Servicesなどと連携し部門横断で業務を推進した実績
- 臨床科学情報を正確かつ効果的に医療従事者へ説明プレゼンできる能力
- 指示待ちではなく自ら考え行動し物事を前に進めるHands on型の働き方ができること
- 英語力があれば尚可グローバルとのコミュニケーションや科学資料の読解が発生
- 約6070テリトリーにより変動の出張に対応でき必要に応じて宿泊を伴う出張が可能であること
- 成果のみならず質的な貢献を通じ担当エリアを超えて組織全体にポジティブな影響を与えられること
Position Summary:
ultrafocused Work together to fearlessly uncover new possibilities
Ultragenyx Japan isseekinghighly drivenUltraCareLiaisons who can independently lead business activities within their assigned territories to deliver innovative therapies in rare diseases. This role willbe responsible forfield engagement forMPS VIIHoFH and the LCFAOD therapyplanned for launch in 2026operatingin a deeply patientfocused environment. We seek individuals with strong business acumen excellent communication skills and a proventrack recordinestablishingand expanding sales in new or evolving markets. For those passionate about making a meaningful impactinrare diseases this positionrepresentsa unique and exceptional career opportunity.
Work Model:
Field: Officially documented as working as a member of the Ultragenyx field team generally interacting with third parties on behalf of Ultragenyx.
Responsibilities:
- Develop and execute territory business plans forMPS VIIHoFH and the launch plan forLC-FAODtreatmentswithin the assigned territory to achieve sales targets.
- Act as the territory business owner conducting impact and territory analyses tooptimizepatient diagnosis HCP education and treatment access.
- Drive patient identification and market development by building and executing territory and account plans continuously assessing opportunities to sustain and grow the business.
- Build effective relationships with internal and external stakeholders adapting communication styles to drive alignment andfacilitatedecisions.
- Engage with current and potential KOLs and HCPs in alignment with Ultragenyx policies SOPs and compliance requirements.
- Develop and execute daily/weekly travel and call plans to ensure optimal and efficient coverage across key accounts.
- Ensuretimelyandaccuratecollection of postmarketing surveillance (PMS) data and collaborate with relevant teams on reporting.
- Contribute to building internal processes and business rules in a start-up environment demonstrating impact beyond the assigned territory at a national level.
Requirements:
- Bachelors degree or higher with 10 years of business experience inscience relatedfields including 8 years in healthcare or biotechnology. Experience in rare diseasesFamilial Hypercholesterolemia (HoFH) or metabolic disorders is highly preferred.
- Strategic business acumen with the ability to naturally lead and influence stakeholders.
- Demonstratedcross functionalcollaboration with medical clinical operations patient services and other internal stakeholders.
- Ability to effectively present and explain clinical and scientific information to healthcare professionals.
- Hands on mindset with the ability to think independently act proactively and drive initiatives forward.
- Englishproficiencyis an asset particularly for engaging with global teams and reviewing scientific materials.
- Ability to travelapproximately 6070% of the time (depending on territory) including required overnight travel.
- Ability to deliver qualitative impact beyond the assigned territory and contribute positivelyatthe broader organizational level.
#LI-CK1 #LI-Remote
Ultragenyx Pharmaceutical is an equal opportunity employer and prohibits unlawful discrimination based on race color religion gender sexual orientation gender identity/expression national origin/ancestry age disability marital and veteran status and any other status or classification protected by applicable federal state and/or local laws. Reasonable accommodation will be provided for all protected statuses or classifications protected by applicable law including individuals with disabilities disabled veterans for pregnancy childbirth and related medical conditions and based on sincerely held religious beliefs. Applicants can request an accommodation prior to accepting a job offer. If you require reasonable accommodation in completing this application or in any part of the recruitment process you may contact Talent Acquisition by emailing us at .
It is unlawful in Massachusetts to require or administer a lie detector test as a condition of employment or continued employment. An employer who violates this law shall be subject to criminal penalties and civil liability.
Key Skills
- Presentation Skills
- Time Management
- Clinical Research
- Communication skills
- GCP
- Infusion Experience
- Managed Care
- Hospice Care
- Conflict Management
- Clinical Trials
- Research Experience
- Home Care
About Company
Ultragenyx is focused on developing first-ever approved treatments for rare and ultrarare diseases and moving the rare disease community forward.
